Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ketamine and Neuropathic Pain

To see complete record on, please visit this link

Id: NCT02467517

Organisation Name: University Hospital, Clermont-Ferrand

Overal Status: Unknown status

Start Date: November 2015

Last Update: July 29, 2016

Lead Sponsor: University Hospital, Clermont-Ferrand

Brief Summary: The primary outcome is to compare the analgesic efficacy of intravenous ketamine treatment to that of a placebo in patients with refractory neuropathic pain.

The secondary outcomes are:

- To compare the additive analgesic efficacy of prior administration of magnesium sulfate to that of placebo and ketamine only, on the effectiveness of intravenous ketamine treatment,
- To study the evolution time of pain and analgesia after the intravenous administration of ketamine and placebo,
- To study the correlation of the analgesic response to administered products respectively ketamine, ketamine and magnesium sulfate, placebo.

  • Neuropathic Pain

Total execution time in seconds: 0.21286201477051